Clinical Trial Update: Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating whether colchicine plus low-dose rivaroxaban can reduce major adverse cardiovascular events after ischemic stroke; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• COLCHICINE (Colchicine)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Brazilian Clinical Research Institute | Conditions: Ischemic Stroke | Phase 4 | Status: NOT_YET_RECRUITING